Browsing Tag
United States
338 posts
Canada to woo U.S. H-1B holders with new immigration offer as Carney outlines strategy
Canada eyes U.S. H-1B visa holders with a new offer as PM Carney promises swift action. Find out how this move could reshape global tech talent flows.
Why Merck’s MSD is paying up to $600m for Evaxion’s undisclosed vaccine candidate EVX-B3
MSD licenses Evaxion’s AI-discovered vaccine EVX-B3 with $7.5M upfront and up to $592M in milestones—why this risky biotech bet could redefine vaccines.
Trump strikes $14bn TikTok deal: Can US investor control secure the app’s future?
Trump’s deal puts TikTok under U.S. investor control in a $14B restructuring. Find out what it means for users, investors, and digital sovereignty today.
Trump’s 100% tariff on branded pharmaceuticals without U.S. plants shocks global drugmakers
Trump’s 100% tariff on branded drugs without U.S. plants could double costs, disrupt supplies, and reshape global pharma strategies. Read what’s at stake.
The global transformer crunch: Why this hidden bottleneck could stall the energy transition
Transformer shortages are emerging as a critical bottleneck in the energy transition. Find out why demand is surging and how it could reshape global grids.
Is pharma nationalism reshaping global R&D? What GSK, Eli Lilly, and AstraZeneca are signaling to the world
GSK, Eli Lilly and AstraZeneca are reshaping global pharma strategy with massive U.S. investments—find out what this means for R&D, supply chains, and policy.
Aramco’s green retreat: What the failed Repsol deal reveals about Big Oil’s future
Aramco paused a €1B bid for Repsol’s renewables unit. Learn why talks stalled, what it means for valuations, and how investors should respond.
How Celltrion’s $330m Eli Lilly deal positions it for a new era of U.S. biomanufacturing
Celltrion’s $330M purchase of Eli Lilly’s U.S. plant signals a tariff-proof pivot in biosimilars, reshaping pharma manufacturing in the U.S. today.
Boeing secures key Asia win as Vietjet receives first 737-8 from $32bn order
Vietjet’s first Boeing 737-8 delivery from its $32B order marks a fleet shift, investor focus on Boeing (NYSE: BA), and deeper US-Vietnam ties.
The environmental footprint of nuclear power: Balancing benefits and trade-offs
Compare nuclear’s carbon savings, land use, and safety with other energy sources—discover why it may be greener than you think.